First Interstate Bank’s Teva Pharmaceuticals TEVA Stock Holding History

First Interstate Bank’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,000	Closed	-$28K	–	667
2019 Q2	$28K	Buy	+3,000	New	+$36.2K	0.01%	416
2017 Q4	–	Sell	-65	Closed	-$1K	–	730
2017 Q3	$1K	Sell	65 -323	-83%	-$7.27K	﹤0.01%	680
2017 Q2	$13K	Hold	388	–	–	﹤0.01%	519
2017 Q1	$12K	Hold	388	–	–	﹤0.01%	521
2016 Q4	$14K	Sell	388 -11,390	-97%	-$455K	﹤0.01%	519
2016 Q3	$542K	Buy	11,778 +1,525	+15%	+$79.6K	0.11%	111
2016 Q2	$515K	Hold	10,253	–	–	0.11%	111
2016 Q1	$549K	Buy	10,253 +3,400	+50%	+$199K	0.12%	102
2015 Q4	$450K	Sell	6,853 -3,950	-37%	-$244K	0.09%	124
2015 Q3	$610K	Buy	+10,803	New	+$700K	0.13%	87

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

First Interstate Bank's TEVA Position: Q3 2019 in Review

First Interstate Bank sold out of Teva Pharmaceuticals (TEVA) in Q3 2019, closing a stake of 3,000 shares — an estimated $28K sold.

First Interstate Bank first reported a position in TEVA in Q3 2015 and held it in 10 quarters. The position peaked at $610K in Q3 2015. 427 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

First Interstate Bank reported no remaining Teva Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
First Interstate Bank sold 3,000 Teva Pharmaceuticals shares in Q3 2019, an estimated $28K.
First Interstate Bank first reported a position in Teva Pharmaceuticals in Q3 2015 and held it in 10 quarters.
First Interstate Bank's Teva Pharmaceuticals position peaked at $610K in Q3 2015.
427 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on First Interstate Bank's 13F filing for Q3 2019, filed 30 Oct 2019.